Bibliography

Abbott J, Hawe J, Hunter D, Garry R: A double-blind randomized trial comparing the Cavaterm™ and the NovaSure® endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 2003;80(1):203-8.

Abbott J, Hawe J, Garry R: Quality of life should be considered the primary outcome for measuring success of endometrial ablation. J Am Assoc Gynecol Laparosc 2003;10(4):491-5.

Baskett T, Clough H, Scott T: NovaSure Bipolar Radiofrequency Endometrial Ablation: Report of 200 Cases. J Obstet Gynaecol Can 2005;27(5):473-6.

Bongers MY, Bourdrez P, Heintz AP, Brolmann HA, Mol BW.: Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation in dysfunctional uterine bleeding: impact on patients' health-related quality of life. Fertil Steril 2005;83(3):724-34.

Bongers M, Bourdrez P, Mol B, Heintz A, Brolmann H: Randomized controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. Obstet Gynecol Surv 2005;60(2):93-4.

Bongers M, Bourdrez P, Mol B, Heintz A, Brolmann H: Randomized controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG 2004;111:1095–1102. *

Please note: Access to the Bongers .pdf file requires visitors to
download and install the DocuRights plug-in.

Bradley L: New endometrial ablation techniques for treatment of menorrhagia. Surg Technol Int 2004;12:161-70.

Busund B, Erno L, Gronmark A, Istre O: Endometrial ablation with NovaSure® GEA, a pilot study. Acta obstetricia et gynecologica Scandinavica. 2003;82(1):65-8.

Cooper J, Gimpleson R: Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 2004;49(4):267-73.

Cooper J, Gimpleson R, Laberge P, Galen D, Garza-Leal J, Scott J, Leyland N, Martyn P, Liu J: A randomized, multicenter trial of safety and efficacy of the NovaSure® System in the treatment of menorrhagia. J Am Assoc Gynecol Laparoscop 2002;9(4):418-28. *

Cooper J: NovaSure® GEA Technology Overview. Analysis of Worldwide Clinical Results. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001. *

Cooper J, Brill A, Fulop T. Is endometrial pretreatment necessary in NovaSure 3-D endometrial ablation? Gynaecologic Endoscopy 2001 10(3):179-82.

Donnadieu AC, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H. Essure sterilization associated with endometrial ablation. Int J Gynecol Obstet 2007; March 20 [Epub ahead of print].

Fadare O, Qin L, Martel M, tavassoli FA: Pathology of the NovaSure (radio-frequency) impedance-controlled endometrial ablation system. Arch Pathol Lab Med 2005;129(9):1175-8.

Fulop T, Rakoczi I, Barna I. NovaSure impedance controlled endometrial ablation: Long-term follow-up results. J Minim Invasive Gynecol 2007;14(1):85-90.

Fulop T, Rakoczi I, Barna I: NovaSure® Impedance Controlled Endometrial Ablation System. Long-term Follow-up Results. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001. *

Gallinat A: NovaSure® Impedance-Controlled System for Endometrial Ablation: Three-year Follow-up on 107 Patients. Am J Obstet Gynecol 2004;191(5):1585-9.

Gallinat A, Nugent W: NovaSure® Impedance-Controlled System for Endometrial Ablation. J Am Assoc Gynecol Laparoscop 2002;9(3):283-9. *

Laberge P, Sabbah R, Fortin C, Gallinat A: Assessment and Comparison of Intraoperative and Postoperative Pain Associated with NovaSure® and ThermaChoice Endometrial Ablation Systems. J Am Assoc Gynecol Laparoscop 2003;10(2):223-32. *

Laberge P: NovaSure GEA Technology Overview. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001. *

Sabbah R, Desaulniers G. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study. J Minim Invasive Gynecol 2006;13(5):467-71.

Sharp H. Assessment of New Technology in the Treatment of Idiopathic Menorrhagia and Uterine Leiomyomata. Obstet and Gynecol 2006;108(4):990-1003.

* To view these .pdf files you must have Adobe Acrobat Reader®, which can be downloaded for free.